Drug intelligence / Profile preview

parecoxib + celecoxib

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Intravenous, Oral
01

Overview

Parecoxib + celecoxib is a sequential analgesic regimen consisting of intravenous parecoxib followed by oral celecoxib. This combination therapy utilizes two selective COX-2 inhibitors for postoperative pain management. Parecoxib is a water-soluble injectable prodrug of valdecoxib that can be used perioperatively when patients are unable to take oral medications. Celecoxib is an oral COX-2 selective inhibitor that provides continued pain relief after the initial parecoxib administration. The sequential regimen has been shown to reduce morphine consumption, achieve better pain control, improve functional recovery, and lead to fewer adverse events compared to placebo in various surgical settings.

Brand names
Dynastat + Celebrex
Other names
sequential parecoxib/celecoxib regimenparecoxib/celecoxib sequential treatment
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on parecoxib + celecoxib.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on parecoxib + celecoxib.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call